Refreshing results…
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
UploadEpigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer
Download from doi.orgMissing publications? Search for publications with a matching author name.